These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 6139479
1. Pyridinylpiperazines, a new class of selective alpha 2-adrenoceptor antagonists. Saari WS, Halczenko W, King SW, Huff JR, Guare JP, Hunt CA, Randall WC, Anderson PS, Lotti VJ, Taylor DA. J Med Chem; 1983 Dec; 26(12):1696-701. PubMed ID: 6139479 [Abstract] [Full Text] [Related]
2. Adrenoceptor and tetrabenazine antagonism activities of some pyridinyltetrahydropyridines. Saari WS, Halczenko W, Huff JR, Guare JP, Hunt CA, Randall WC, Lotti VJ, Yarbrough GG. J Med Chem; 1984 Sep; 27(9):1182-5. PubMed ID: 6088770 [Abstract] [Full Text] [Related]
3. Alpha-adrenoceptor antagonism by apoyohimbine and some observations on the pharmacology of alpha-adrenoceptors in the rat anococcygeus and vas deferens. McGrath JC. Br J Pharmacol; 1984 Aug; 82(4):769-81. PubMed ID: 6148114 [Abstract] [Full Text] [Related]
4. A difference in the affinity of some selective alpha 2-adrenoceptor antagonists when compared on isolated vasa deferentia of rat and rabbit. Lattimer N, Rhodes KF. Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):278-81. PubMed ID: 2862589 [Abstract] [Full Text] [Related]
5. Studies of alpha 2-adrenoceptor antagonist potency in vitro: comparisons in tissues from rats, rabbits, dogs and humans. Waterfall JF, Rhodes KF, Lattimer N. Clin Sci (Lond); 1985 May; 68 Suppl 10():21s-24s. PubMed ID: 2857614 [Abstract] [Full Text] [Related]
6. L-654,284 a new potent and selective alpha 2-adrenoceptor antagonist. Pettibone DJ, Clineschmidt BV, Lotti VJ, Martin GE, Huff JR, Randall WC, Vacca J, Baldwin JJ. Naunyn Schmiedebergs Arch Pharmacol; 1986 Jun; 333(2):110-6. PubMed ID: 2875395 [Abstract] [Full Text] [Related]
7. Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitro. Perrone MH, Hamel LT, Ferrari RA, Haubrich DR. J Pharmacol Exp Ther; 1990 Aug; 254(2):471-5. PubMed ID: 1974637 [Abstract] [Full Text] [Related]
8. Pharmacological profile of a new potent and specific alpha 2-adrenoceptor antagonist, L-657,743. Pettibone DJ, Clineschmidt BV, Lotti VJ, Baldwin JJ, Huff JR, Randall WC, Vacca J, Young SD. Naunyn Schmiedebergs Arch Pharmacol; 1987 Aug; 336(2):169-75. PubMed ID: 2891039 [Abstract] [Full Text] [Related]
9. Evidence for pharmacological similarity between alpha 2-adrenoceptors in the vas deferens and central nervous system of the rat. Doxey JC, Gadie B, Lane AC, Tulloch IF. Br J Pharmacol; 1983 Sep; 80(1):155-61. PubMed ID: 6140052 [Abstract] [Full Text] [Related]
10. Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies. Ohmura T, Oshita M, Kigoshi S, Muramatsu I. Br J Pharmacol; 1992 Nov; 107(3):697-704. PubMed ID: 1361871 [Abstract] [Full Text] [Related]
11. Selectivity of blocking agents for pre-and postsynaptic alpha-adrenoceptors. Doxey JC, Smith CF, Walker JM. Br J Pharmacol; 1977 May; 60(1):91-6. PubMed ID: 18248 [Abstract] [Full Text] [Related]
12. alpha-Adrenergic activities of some substituted 2-(aminomethyl)imidazolines. Saari WS, Halczenko W, Randall WC, Lotti VJ. J Med Chem; 1983 Dec; 26(12):1769-72. PubMed ID: 6139481 [Abstract] [Full Text] [Related]
13. Subclassification of alpha 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists. Hanft G, Gross G. Br J Pharmacol; 1989 Jul; 97(3):691-700. PubMed ID: 2569345 [Abstract] [Full Text] [Related]
14. In vitro studies with (imidazolinyl-2)-2-benzodioxane-1-4 ((+/-)-170 150), a new potent alpha 2-adrenoceptor blocking agent. Dabiré H, Dausse JP, Mouillé P, Schmitt H, Meyer P. Eur J Pharmacol; 1982 Dec 17; 86(1):87-90. PubMed ID: 6130957 [Abstract] [Full Text] [Related]
15. alpha(2)-adrenoceptor antagonist properties of OPC-28326, a novel selective peripheral vasodilator. Orito K, Kishi M, Imaizumi T, Nakazawa T, Hashimoto A, Mori T, Kambe T. Br J Pharmacol; 2001 Oct 17; 134(4):763-70. PubMed ID: 11606316 [Abstract] [Full Text] [Related]
16. Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors. Doxey JC, Roach AG, Smith CF. Br J Pharmacol; 1983 Mar 17; 78(3):489-505. PubMed ID: 6132640 [Abstract] [Full Text] [Related]
17. Alpha 1-adrenoceptor antagonist activity of novel pyrimidine derivatives (SHI437 and IK29) in rabbit aorta and trigone of the bladder. Azuma H, Sugimoto-Tokushima M, Tanaka K, Ikenoue Y, Ito S, Ishikawa M. Br J Pharmacol; 1989 Apr 17; 96(4):1000-6. PubMed ID: 2568139 [Abstract] [Full Text] [Related]
18. The adrenoceptor agonist, SDZ NVI 085, discriminates between alpha 1A- and alpha 1B-adrenoceptor subtypes in vas deferens, kidney and aorta of the rat. Eltze M, Boer R. Eur J Pharmacol; 1992 Dec 02; 224(2-3):125-36. PubMed ID: 1361446 [Abstract] [Full Text] [Related]
19. Differential blocking actions of idazoxan against the inhibitory effects of 6-fluoronoradrenaline and clonidine in the rat vas deferens. Hicks PE, Langer SZ, Macrae AD. Br J Pharmacol; 1985 Sep 02; 86(1):141-50. PubMed ID: 2864967 [Abstract] [Full Text] [Related]
20. Evidence for a functional alpha 1A- (alpha 1C-) adrenoceptor mediating contraction of the rat epididymal vas deferens and an alpha 1B-adrenoceptor mediating contraction of the rat spleen. Burt RP, Chapple CR, Marshall I. Br J Pharmacol; 1995 Jun 02; 115(3):467-75. PubMed ID: 7582458 [Abstract] [Full Text] [Related] Page: [Next] [New Search]